Ads
related to: merck pharmaceuticals
Search results
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 5 days agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe latest development comes after Merck announced an investment of more than €300m ($320.8m) in a...
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 6 days agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share (EPS) of 0.9, the question ...
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 6 days agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a pipeline of vision ...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News via Yahoo News· 3 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
US Duo Takes On Merck's $3B Acquisition Of EyeBio | Law.com International
Law.com· 5 days agoSkadden Arps Slate Meagher & Flom and Gibson Dunn & Crutcher have taken on lead roles in New...
CNS Pharmaceuticals Announces Reverse Stock Split
Digital Journal· 14 hours agoProvides Update on Ironton Purification Facility Gryphon Digital Mining set to join Russell Microcap(R) Index Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in ...
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 6 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe open-label Phase III study is expected to enrol approximately 275 participants with recurrent...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks· 22 hours agoFree Report) , a passively managed exchange traded fund launched on 06/23/2005. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional ...
